10.63
+0.03(+0.28%)
Currency In USD
| Previous Close | 10.6 |
| Open | 10.61 |
| Day High | 10.63 |
| Day Low | 10.61 |
| 52-Week High | 10.7 |
| 52-Week Low | 10.06 |
| Volume | 33,536 |
| Average Volume | 32,946 |
| Market Cap | 305.61M |
| PE | 35.43 |
| EPS | 0.3 |
| Moving Average 50 Days | 10.56 |
| Moving Average 200 Days | 10.44 |
| Change | 0.03 |
If you invested $1000 in Launch One Acquisition Corp. (LPAA) since IPO date, it would be worth $1,066.2 as of January 13, 2026 at a share price of $10.63. Whereas If you bought $1000 worth of Launch One Acquisition Corp. (LPAA) shares 1 year ago, it would be worth $1,057.71 as of January 13, 2026 at a share price of $10.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
GlobeNewswire Inc.
2 hours ago
New U.S. intellectual property protections expand use of Minovia’s leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseasesHAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“
Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition
GlobeNewswire Inc.
Nov 20, 2025 1:30 PM GMT
Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in Shaare Zedek Medical Center show high safety profile a
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
GlobeNewswire Inc.
Oct 15, 2025 11:30 AM GMT
Regulatory Milestone Adds to Fast-Track Designation Providing Further Potential Regulatory Advantages as Company Develops First-in-Class Mitochondrial Cell TherapyHAIFA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia”